Pharmaceutical major Johnson & Johnson (JNJ) has reported mixed results for the third quarter of 2021. Following the news, shares of the company appreciated 2.3% to close at $164.10 in extended trade on Tuesday. Johnson & Johnson reported quarterly revenues of $23.3 billion, up 10.7% from the previous year’s figure of $21 billion. The growth was primarily driven by a 13.8% year-over-year rise in sales witnessed in the `Pharmaceutical segment from $11.4 billion to $12.9 billion. The segment made up about 55.7% of the total sales for the quarter. Other segments like Consumer Health and Medical Devices witnessed year-over-year sales growth of 5.3% and 8%, respectively.
https://www.tipranks.com/news/johnson-shares-rise-2-3?utm_source=advfn.com&utm_medium=referral
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Nov 2021 to Dec 2021 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Dec 2020 to Dec 2021 Click Here for more Johnson and Johnson Charts.